Study identifier:NIS-RCN-XXX-2013/2
ClinicalTrials.gov identifier:NCT02143739
EudraCT identifier:N/A
CTIS identifier:N/A
The severity of newly diagnosed asthma patients and the result of initial 12 weeks treatment in China.
asthma
N/A
No
-
All
4817
Observational
18 Years +
Allocation: N/A
Endpoint Classification: -
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: -
Verified 01 Sept 2017 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|---|
Newly diagnosed asthma patients The patient population will be outpatients, men or women, ≥18 years of age, Newly diagnosed asthma patients who are not on inhaled gluococorticosteroid within 3 months.The patient population should not have COPD(chronic obstructive pulmonary diseases) history, or asthma exacerbation. | - |